His decision came as an investigation into sexual harassment allegations against him was ongoing.
A molecule produced by a strain of Staphylococcus epidermis interferes with DNA synthesis.
The Scientist
Most Recent
Researchers unravel the sophisticated ways cancers evade treatments, including immunotherapies, designed to destroy them.
Cancers appear to be able to evolve resistance to many of the therapies doctors have tried.
Neoantigens may serve as valuable targets for new immunotherapies.
Researchers find diverse ways that the molecules can regulate cancer’s spread.
Clusters of tumor-derived cells can pass through narrow channels that mimic human capillaries, scientists show in vitro and in zebrafish.
Drug-delivering nanoparticles designed to glow when their target cells die can report on the effectiveness of cancer therapies within just a few hours of treatment, a mouse study shows.
While exploring the genetics of a rare type of tumor, Stephen Baylin discovered an epigenetic modification that occurs in most every cancer—a finding he’s helping bring to the clinic.
Page 1 of 1
Popular Now
-
The Nutshell Prominent Salk Institute Scientist Inder Verma Resigns -
The Nutshell Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study The company’s announcement comes weeks after enrollment was suspended.
-
The Nutshell Dartmouth Professor Investigated for Sexual Misconduct Retires Todd Heatherton had groped students, according to allegations, and was facing termination.
-
News Analysis North American Universities Increasingly Cancel Publisher Packages A growing number of libraries are unbundling their subscriptions to the full suite of publishers’ journals, opting for limited titles to save on costs.
Current Issue
© 1986-2018 The Scientist
